Laman UtamaGOVXW • NASDAQ
add
GeoVax
Tutup sebelumnya
$0.14
Julat hari
$0.12 - $0.15
Julat tahun
$0.020 - $34.93
Permodalan pasaran
27.84J USD
Bilangan Purata
16.01K
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 2.79J | — |
Perbelanjaan pengendalian | 1.24J | -24.86% |
Pendapatan bersih | -5.82J | 30.84% |
Margin untung bersih | -208.48 | — |
Pendapatan bagi setiap syer | — | — |
EBITDA | -5.82J | 32.14% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 8.59J | -32.27% |
Jumlah aset | 11.11J | -31.41% |
Jumlah liabiliti | 2.61J | -63.17% |
Jumlah ekuiti | 8.50J | — |
Syer tertunggak | 9.44J | — |
Harga kepada buku | 0.14 | — |
Pulangan pada aset | -192.49% | — |
Pulangan pada modal | -461.94% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -5.82J | 30.84% |
Tunai daripada operasi | -9.30J | -82.45% |
Tunai daripada pelaburan | -20.65K | -233.54% |
Tunai daripada pembiayaan | 16.35J | — |
Perubahan bersih dalam tunai | 7.03J | 237.81% |
Aliran tunai bebas | -7.18J | -234.67% |
Perihal
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
Diasaskan
1988
Ibu pejabat
Tapak web
Pekerja
17
